SOLARA vs VINEETLAB: Stock Comparison

Solara Active Pharma Sciences Limited vs Vineet Laboratories Limited

Live data: 28 July 2026, 4:08 PM IST • Source: NSE and company filings

Solara Active Pharma Sciences Limited is the larger company by market capitalisation. Solara Active Pharma Sciences Limited shows faster revenue growth, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Solara Active Pharma Sciences Limited and Vineet Laboratories Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, SOLARA is more favourable on 8 of 10 scored metrics and VINEETLAB on 0These counts are context-free and are not an overall rating.

Key Differences

Market Cap
SOLARA is the larger company
₹2,445 Cr vs ₹75 Cr
EPS
SOLARA has higher earnings per share
₹-1.68 vs ₹-20.47
Revenue Growth (TTM YoY)
SOLARA has faster revenue growth
41.9% vs 11.05%
Qtr Sales Growth
SOLARA has stronger quarterly sales growth
41.9% vs -68.8%
Qtr Profit Growth
SOLARA has stronger quarterly profit growth
516% vs 59.2%
ROCE
SOLARA has a higher ROCE
4.86% vs -28%
Net Margin
SOLARA has a higher net margin
-0.54% vs -26.92%
Operating Margin
SOLARA has a higher operating margin
13.6% vs -22.4%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricSOLARAVINEETLAB
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricSOLARAVINEETLAB
Live Price₹507₹38.55
Day Change0.4%5.79%
Volume1.94 L2.02 L
52-Week High₹712₹49.99
52-Week Low₹422₹27.96
Distance from 52W High-28.79%-22.88%

Valuation

MetricSOLARAVINEETLAB
Market Cap₹2,445 Cr₹75 Cr
P/E Ratio-1,492.06x
P/B Ratio1.95x
EPS₹-1.68₹-20.47
Book Value₹287.12₹15.84
Dividend Yield0%0%

Growth

MetricSOLARAVINEETLAB
Revenue Growth (TTM YoY)41.9%11.05%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth41.9%-68.8%
Qtr Profit Growth516%59.2%

Profitability & Leverage

MetricSOLARAVINEETLAB
ROE-0.13%
ROCE4.86%-28%
Net Margin-0.54%-26.92%
Operating Margin13.6%-22.4%
Debt to Equity0.55x2.73x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricSOLARAVINEETLAB
Promoter Holding41.93% 0.07 pp5.98% 6.48 pp
FII Holding11.52% 0.19 pp0.36% 0.36 pp
DII Holding3.74% 0.04 pp
Public Holding42.81% 0.08 pp93.66% 6.12 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Solara Active Pharma Sciences Limited and Vineet Laboratories Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.